(2021) Liposomal doxorubicin targeting mitochondria: A novel formulation to enhance anti-tumor effects of Doxil (R) in vitro and in vivo. Journal of Drug Delivery Science and Technology. p. 13. ISSN 1773-2247

(2019) Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study. International Journal of Pharmaceutics. p. 9. ISSN 0378-5173

(2019) Cytotoxicity, stimulatory and antitumor effects of liposomal delivery vehicles in cancer immunotherapies. European Journal of Immunology. pp. 1823-1824. ISSN 0014-2980